Evidence map›Paper›PMID 21734046›Full record

ArticleJournal of virology2011

HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.

Genevieve G Fouda, Nicole L Yates, Justin Pollara, Xiaoying Shen, Glenn R Overman, Tatenda Mahlokozera, Andrew B Wilks, Helen H Kang, Jesus F Salazar-Gonzalez, Maria G Salazar and 13 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 94 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Increase in SARS-CoV-2 RBD-Specific IgA and IgG Antibodies in Human Milk From Lactating Women Following the COVID-19 Booster Vaccination.Journal of human lactation : official journal of International Lactation Consultant Association · 2023
    Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Genevieve G FoudaDuke Human Vaccine Institute, Duke University Medical Center, Box 103020, Durham, NC 27710, USA.
Nicole L Yates
Justin Pollara
Xiaoying Shen
Glenn R Overman
Tatenda Mahlokozera
Andrew B Wilks
Helen H Kang
Jesus F Salazar-Gonzalez
Maria G Salazar
Linda Kalilani
Steve R Meshnick
Beatrice H Hahn
George M Shaw
Rachel V Lovingood
Thomas N Denny
Barton Haynes
Norman L Letvin
Guido Ferrari
David C Montefiori
Georgia D Tomaras
Sallie R Permar
Center for HIV/AIDS Vaccine Immunology
Duke Medical Center · USUniversity of Alabama at Birmingham · USHarvard University · USBeth Israel Deaconess Medical Center · USUniversity of Malawi · MWUniversity of North Carolina at Chapel Hill · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI LETVIN, NORMAN L · 2006 to 2011
$290.5M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
Ruth L. Kirschstein National Research Service Award (NRSA)- T32T32AI007392 · NIAID · DUKE UNIVERSITY · PI Amy Lynn Corneli, Guido Ferrari · 1990 to 2026
$9.8M
SIV-specific Immunity in breast milk during infection and after vaccinationK08AI087992 · NIAID · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2009 to 2013
$568k
NIAID NIH HHS AI067854NIAID NIH HHS K08 AI087992NIAID NIH HHS K08AI087992NIAID NIH HHS P30 AI060354NIAID NIH HHS T32 AI007392NIAID NIH HHS U01 AI067854NIAID NIH HHS U19 AI067854
6 · The paper itself

Abstract

Despite months of mucosal virus exposure, the majority of breastfed infants born to HIV-infected mothers do not become infected, raising the possibility that immune factors in milk inhibit mucosal transmission of HIV. HIV Envelope (Env)-specific antibodies are present in the milk of HIV-infected mothers, but little is known about their virus-specific functions. In this study, HIV Env-specific antibody binding, autologous and heterologous virus neutralization, and antibody-dependent cell cytotoxicity (ADCC) responses were measured in the milk and plasma of 41 HIV-infected lactating women. Although IgA is the predominant antibody isotype in milk, HIV Env-specific IgG responses were higher in magnitude than HIV Env-specific IgA responses in milk. The concentrations of anti-HIV gp120 IgG in milk and plasma were directly correlated (r = 0.75; P < 0.0001), yet the response in milk was 2 logarithm units lower than in plasma. Similarly, heterologous virus neutralization (r = 0.39; P = 0.010) and ADCC activity (r = 0.64; P < 0.0001) in milk were directly correlated with that in the systemic compartment but were 2 log units lower in magnitude. Autologous neutralization was rarely detected in milk. Milk heterologous virus neutralization titers correlated with HIV gp120 Env-binding IgG responses but not with IgA responses (r = 0.71 and P < 0.0001, and r = 0.17 and P = 0.30). Moreover, IgGs purified from milk and plasma had equal neutralizing potencies against a tier 1 virus (r = 0.65; P < 0.0001), whereas only 1 out of 35 tested non-IgG milk fractions had detectable neutralization. These results suggest that plasma-derived IgG antibodies mediate the majority of the low-level HIV neutralization and ADCC activity in breast milk.

Indexed as

Antibody FormationAntibodies, NeutralizingAntibody-Dependent Cell CytotoxicityCross Reactionsenv Gene Products, Human Immunodeficiency VirusFemaleHIV AntibodiesHIV InfectionsHumansImmunoglobulin AImmunoglobulin GMilk, HumanNeutralization TestsPlasmaAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesImmunoglobulin AImmunoglobulin G

Identifiers

PMID21734046
PMCPMC3165739
OpenAlexW2100890648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.